Formulations of oxabicycloheptanes and oxabicycloheptenes Grant US-11931354-B2 United States of America 19 Mar 2024
Cell-based neoantigen vaccines and uses thereof Grant US-11723962-B2 United States of America 15 Aug 2023
Methods and compositions for cellular immunotherapy Grant US-11564947-B2 United States of America 31 Jan 2023
High affinity MAGE-A1-specific TCRs and uses thereof Grant US-11034748-B2 United States of America 15 Jun 2021
Compositions and methods for boosting the efficacy of adoptive cellular immunotherapy Grant US-10828352-B2 United States of America 10 Nov 2020
Methods and compositions for cellular immunotherapy Grant US-10780119-B2 United States of America 22 Sep 2020
Inhibitors of immune checkpoint modulators and related methods Grant US-10702526-B2 United States of America 07 Jul 2020
3-indol substituted derivatives, pharmaceutical compositions and methods for use Grant US-10544095-B2 United States of America 28 Jan 2020
T cell immunotherapy specific for WT-1 Application US-10538572-B2 United States of America 21 Jan 2020
IMMUNOGENIC COMPOSITION FOR THE TREATMENT OF CANCER Application WO-2019063829-A1 World Intellectual Property Organisation (WIPO) 04 Apr 2019
3-indol substituted derivatives, pharmaceutical compositions and methods for use Grant US-9873690-B2 United States of America 23 Jan 2018
Anti-FZD10 monoclonal antibodies and methods for their use Grant US-9777065-B2 United States of America 03 Oct 2017
CYCLODEXTRIN CARRIER-BASED ARTEANNUIN COMPOUND CONJUGATE AND PREPARING METHOD THEREOF Application EP-2974743-A4 European Patent Office 27 Jul 2016
4-(indol-3-yl)-pyrazole derivatives, pharmaceutical compositions and methods for use Application US-9126984-B2 United States of America 08 Sep 2015
Anti-FZD10 monoclonal antibodies and methods for their use Grant US-9102724-B2 United States of America 11 Aug 2015